Seeing Is Believing
Currently out of the existing stock ratings of Alexander Nowak, 87 are a BUY (83.65%), 15 are a HOLD (14.42%), 2 are a SELL (1.92%).
Analyst Alexander Nowak, currently employed at CRAIG HALLUM, carries an average stock price target met ratio of 44.3% that have a potential upside of 52.89% achieved within 147 days.
Alexander Nowak’s has documented 228 price targets and ratings displayed on 17 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on QDEL, Quidel at 05-Sep-2024.
Analyst best performing recommendations are on CDNA (CAREDX).
The best stock recommendation documented was for CDNA (CAREDX) at 5/1/2024. The price target of $15 was fulfilled within 13 days with a profit of $5.82 (63.4%) receiving and performance score of 48.77.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
40
$12.9 (47.60%)
19 days ago
2/6 (33.33%)
$6.01 (17.68%)
294
Buy
26
$-1.1 (-4.06%)
16
1 months 6 days ago
6/8 (75%)
$2.42 (10.26%)
260
Hold
1 months 6 days ago
6/6 (100%)
$5.95 (12.13%)
165
Buy
12
3 months 25 days ago
6/11 (54.55%)
$2.34 (24.22%)
320
Buy
18
$-9.1 (-33.58%)
10
3 months 25 days ago
5/6 (83.33%)
$3.02 (20.16%)
143
Which stock is Alexander Nowak is most bullish on?
Which stock is Alexander Nowak is most reserved on?
What Year was the first public recommendation made by Alexander Nowak?